Short and long-term tumor cell responses to Aurora kinase inhibitors

被引：33

作者：

Dreier, Megan R. ^{[1
]}

Grabovich, Aaron Z. ^{[1
]}

Katusin, Jamie D. ^{[1
]}

Taylor, William R. ^{[1
]}

机构：

[1] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA

来源：

EXPERIMENTAL CELL RESEARCH | 2009年 / 315卷 / 07期

关键词：

Mitosis; Cell cycle; ZM447439; MK-0457; VE-465; ANTICANCER DRUGS; MAMMALIAN-CELLS; PROTEIN-KINASE; B EXPRESSION; G(2) ARREST; IN-VIVO; P53; CANCER; CHECKPOINT; DNA;

D O I：

10.1016/j.yexcr.2009.02.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Aurora kinases are essential for mitosis and are candidate targets of novel chemotherapeutic agents. The inhibitors ZM447439, MK-0457 (VX-680) as well as Hesperadin have been used to dissect the roles of Aurora kinases in the cell cycle and have been tested clinically for the treatment of cancer. Here we have carried out a detailed kinetic analysis of two isogenic cell lines differing in p53 function and have compared the effects of ZM447439 and VE-465 (related to MK-0457). We find that p53 is needed for efficient cell cycle arrest when Aurora kinases are inhibited by either ZM447439 or VE-465. However, the p53-induced cell cycle block is neither immediate nor absolute. ZM447439 induced the localized accumulation of yH2A.X indicating that p53 induction by this drug occurs in response to DNA damage. Our analysis of the long-term effects of ZM447439 indicates that cells can evade killing by the drug, but not via a classical drug-resistance mechanism. Several mechanisms to explain how cells may evade killing by Aurora kinase inhibitors are described. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：1085 / 1099

页数：15

共 43 条

[1]

Cell cycle checkpoint signaling through the ATM and ATR kinases [J].